Mirum Pharmaceuticals MIRM reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Mirum Pharmaceuticals missed estimated earnings by -175.0%, reporting an EPS of $-0.66 versus an estimate of $-0.24.
Revenue was up $41.65 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 6.0% increase in the share price the next day.
Here's a look at Mirum Pharmaceuticals's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.65 | -0.81 | -0.94 | -1.02 |
| EPS Actual | -0.57 | -1.94 | -0.80 | -0.99 |
| Revenue Estimate | 37.12M | 30.00M | 28.69M | 24.57M |
| Revenue Actual | 47.73M | 37.50M | 31.60M | 27.91M |
To track all earnings releases for Mirum Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
